novel immunotherapy combinations in hodgkin lymphoma
Published 2 years ago • 244 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
2:18
novel drug combinations for hodgkin lymphoma: more effective & less toxic
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
13:31
key highlights in mpns: novel agents, combinations, and the potential role of immunotherapy
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
0:57
novel therapeutic strategies in all
-
18:51
is there scientific proof we can heal ourselves? | lissa rankin, md | tedxamericanriviera
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
6:53
my journey with pancreatic cancer diary pt 4
-
2:15
novel combination therapies for the treatment of non-hodgkin lymphoma
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:42
novel treatment combinations in aml: what’s to come?
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
1:48
novel immunotherapy approaches in lymphoma: car-t cells, bispecifics & sequencing
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:32
promising novel immunotherapeutic approaches in lymphoma
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
1:19
novel combination therapy for cmml: jak inhibitor pacritinib plus azacitidine
-
1:55
novel biological therapies for managing non-hodgkin lymphoma